title: Elevated interleukin-1beta induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice.
abstract: IL-1beta is a potent pro-inflammatory cytokine that regulates neuroinflammation during brain damage. The expression of IL-1beta has been reported to be elevated in the striatum and substantia nigra of patients with Parkinson's disease (PD). Moreover, greater prevalence of PD in men than in women is described previously. Here, by using a sensitive mice model in which the expression of luciferase reporter gene is under the control of human IL-1beta gene promoter, we examined IL-1beta gene expression pattern in vivo after subacute MPTP toxication in old male and female mice and found that MPTP elicited greater dopaminergic toxicity in old male than in female mice. Old male mice showed dramatically elevated luciferase signals in a flexuous manner at early period of time, meanwhile, the changes in female were more moderate. However, no significant difference in astroglial reaction was observed at later time point between sexes. In conclusion, the present study demonstrated that elevated IL-1beta gene expression at early period of time may be in part responsible for the DA neuron susceptibility to MPTP in old male mice.
authors.affiliation: State Key Laboratory of Medical Neurobiology, Shanghai Medical College, Fudan University, Shanghai, PR China.
authors.forename: Min-Juan
authors.initials: MJ
authors.lastname: Bian
authors.forename: Li-Mei
authors.initials: LM
authors.lastname: Li
authors.forename: Mei
authors.initials: M
authors.lastname: Yu
authors.forename: Jian
authors.initials: J
authors.lastname: Fei
authors.forename: Fang
authors.initials: F
authors.lastname: Huang
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000367:Age Factors; D000375:Aging / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D005260:Female; D005786:Gene Expression Regulation / Q000276:immunology; D005819:Genetic Markers / Q000276:immunology; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis / Q000378:metabolism; D005911:Gliosis / Q000139:chemically induced / Q000276:immunology / Q000378:metabolism; D018836:Inflammation Mediators / Q000378:metabolism; D053583:Interleukin-1beta / Q000235:genetics / Q000378:metabolism*; D008156:Luciferases / Q000235:genetics; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009410:Nerve Degeneration / Q000276:immunology* / Q000378:metabolism / Q000503:physiopathology; D009474:Neurons / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D009498:Neurotoxins / Q000494:pharmacology; D020734:Parkinsonian Disorders / Q000276:immunology* / Q000378:metabolism / Q000503:physiopathology; D011401:Promoter Regions, Genetic / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D012727:Sex Characteristics; D013378:Substantia Nigra / Q000276:immunology* / Q000378:metabolism / Q000503:physiopathology; D015854:Up-Regulation / Q000276:immunology
chemical_list: D015415:Biomarkers; D016207:Cytokines; D005819:Genetic Markers; D005904:Glial Fibrillary Acidic Protein; D018836:Inflammation Mediators; D053583:Interleukin-1beta; D009498:Neurotoxins; D012333:RNA, Messenger; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008156:Luciferases; D004298:Dopamine